Prognostic Factors for Survival in Patients with Hepatocellular Carcinoma after Percutaneous Microwave Ablation
- 1 April 2005
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 235 (1), 299-307
- https://doi.org/10.1148/radiol.2351031944
Abstract
PURPOSE: To determine the long-term survival and prognostic factors in patients with hepatocellular carcinoma treated with percutaneous microwave ablation. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. A database of cases of hepatocellular carcinoma in 288 patients (259 men, 29 women; mean age, 54.8 years ± 11.4 [standard deviation]; age range, 25–82 years) with 477 histologically proved lesions who underwent percutaneous microwave coagulation therapy between May 1994 and October 2002 was retrospectively analyzed. Prognostic factors for survival were evaluated by means of univariate and multivariate analyses. RESULTS: The mean follow-up period after microwave ablation was 31.41 months ± 20.43 (range, 5–106 months). The 1-, 2-, 3-, 4-, and 5-year cumulative survival rates among all 288 patients were 93%, 82%, 72%, 63%, and 51%, respectively. Ninety-three patients (32%) died. Local recurrence or new tumors occurred in 100 patients (35%). Age (P = .836), sex (P = .073), preablation serum α-fetoprotein level (P = .136), and preablation treatment (P = .256) were not related to prognosis, while tumor number (P = .004), tumor size (P < .001), Child-Pugh classification (P = .003), tumor differentiation (P = .026), and local recurrence or presence of new tumors (P = .004) significantly affected survival at univariate analysis. At multivariate analysis, only tumor size (P < .001), number of nodules (P = .005), and Child-Pugh classification (P = .01) each had a significant effect on survival. CONCLUSION: With use of microwave ablation, there is a high probability of long-term survival of patients with a single lesion of 4.0 cm or less in maximum diameter and Child-Pugh class A cirrhosis. © RSNA, 2005Keywords
This publication has 36 references indexed in Scilit:
- Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular CarcinomaAnnals of Surgery, 2004
- The Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma in the United States Between 1988 and 2001: 5-Year Survival Has Improved Significantly With TimeJournal of Clinical Oncology, 2003
- Computer-aided dynamic simulation of microwave-induced thermal distribution in coagulation of liver cancerIEEE Transactions on Biomedical Engineering, 2001
- Local Ablation Therapy for Hepatocellular CarcinomaSeminars in Liver Disease, 1999
- Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.American Journal of Roentgenology, 1996
- Risk factors for intrahepatic recurrence in human small hepatocellular carcinomaGastroenterology, 1995
- Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinomaCancer, 1993
- Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.American Journal of Roentgenology, 1993
- Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinomaCancer, 1993
- Hepatocellular carcinomaJournal of Hepatology, 1992